Company: BLCO
Filing Date: 2025-08-18
Form Type: 8-K
Source: 0001860742-25-000019
Chunk: 0

Company: Bausch & Lomb Corp
Filing Date: 2025-08-18
Form: 8-K
Item: Item 1.02
Chunk 0
---
Item 1.02

Termination of a Material Definitive Agreement.

In accordance with its terms, the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022 (the “ Director Appointment and Nomination Agreement”), by and among Carl C. Icahn, Icahn Partners LP, Icahn Partners Master Fund LP, Icahn Enterprises G. P. Inc., Icahn Enterprises Holdings L. P., IPH GP LLC, Icahn Capital LP, Icahn Onshore LP, Icahn Offshore LP and Beckton Corp. (collectively, the “ Icahn Group”) and Bausch + Lomb Corporation (“ Bausch + Lomb”) has terminated following the Icahn Group’s net long position in the common shares of Bausch + Lomb’s parent company, Bausch Health Companies Inc., falling below the required threshold in the Director Appointment and Nomination Agreement. The termination of the Director Appointment and Nomination Agreement was effective as of August 14, 2025.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.